Cargando…

Chronic Administration of Cannabinoid Receptor 2 Agonist (JWH-133) Increases Ectopic Ovarian Tumor Growth and Endocannabinoids (Anandamide and 2-Arachidonoyl Glycerol) Levels in Immunocompromised SCID Female Mice

Cannabinoid-based therapies are increasingly being used by cancer patients to treat chemotherapy-induced nausea and vomiting. Recently, cannabinoids have gained increased attention for their effects on cancer growth. Indeed, the effect of CB(2) (JWH-015, JWH-133) agonists on breast cancer models hav...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blanton, Henry L., McHann, Melissa C., De Selle, Haley, Dancel, Canice Lei, Redondo, Jose-Luis, Molehin, Deborah, German, Nadezhda A., Trasti, Scott, Pruitt, Kevin, Castro-Piedras, Isabel, Guindon, Josée
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886292/ https://www.ncbi.nlm.nih.gov/pubmed/35242036 http://dx.doi.org/10.3389/fphar.2022.823132

Ejemplares similares

The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways
por: Bradshaw, Heather B, et al.
Publicado: (2009)

Endocannabinoid 2-arachidonoyl glycerol increases the transcription of daf-7 in ASI neurons
por: Galles, Celina, et al.
Publicado: (2018)

Erratum: Endocannabinoid 2-arachidonoyl glycerol increases the transcription of daf-7 in ASI neurons
Publicado: (2019)

Human and Mouse Eosinophils Differ in Their Ability to Biosynthesize Eicosanoids, Docosanoids, the Endocannabinoid 2-Arachidonoyl-glycerol and Its Congeners
por: Archambault, Anne-Sophie, et al.
Publicado: (2022)

The endocannabinoid anandamide is an airway relaxant in health and disease
por: Simon, Annika, et al.
Publicado: (2022)

The endocannabinoid N-arachidonoyl dopamine is critical for hyperalgesia induced by chronic sleep disruption
por: Ding, Weihua, et al.
Publicado: (2023)

Mechanism and effectiveness of polymyxin B-immobilized fiber columns for removing mediators (HMBG-1, 2-arachidonoyl glycerol, anandamide, PAI-1, protein C and IL-6) in septic shock patients
por: Sakamoto, Y, et al.
Publicado: (2007)

N-Arachidonoyl Dopamine: A Novel Endocannabinoid and Endovanilloid with Widespread Physiological and Pharmacological Activities
por: Grabiec, Urszula, et al.
Publicado: (2017)

Metabolism of the Endocannabinoid Anandamide: Open Questions after 25 Years
por: Maccarrone, Mauro
Publicado: (2017)

Elevation of endocannabinoids in the brain by synthetic cannabinoid JWH-018: mechanism and effect on learning and memory
por: Li, Ren-shi, et al.
Publicado: (2019)

Author Correction: The endocannabinoid N-arachidonoyl dopamine is critical for hyperalgesia induced by chronic sleep disruption
por: Ding, Weihua, et al.
Publicado: (2023)

Assessment of the Abuse Liability of Synthetic Cannabinoid Agonists JWH-030, JWH-175, and JWH-176
por: Tampus, Reinholdgher, et al.
Publicado: (2015)

Effect of N-arachidonoyl-(2-methyl-4-hydroxyphenyl) amine (VDM11), an anandamide transporter inhibitor, on capsaicin-induced cough in mice
por: Kamei, Junzo, et al.
Publicado: (2006)

The Effects of the Endocannabinoids Anandamide and 2-Arachidonoylglycerol on Human Osteoblast Proliferation and Differentiation
por: Smith, Marie, et al.
Publicado: (2015)

The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries
por: Stanley, Christopher P., et al.
Publicado: (2016)

Targeting the Achilles’ Heel of Multidrug-Resistant Staphylococcus aureus by the Endocannabinoid Anandamide
por: Sionov, Ronit Vogt, et al.
Publicado: (2022)

Endocannabinoids, Anandamide and 2-Arachidonoylglycerol, as Prognostic Markers of Sepsis Outcome and Complications
por: Šahinović, Ines, et al.
Publicado: (2023)

Neurotoxicity of Synthetic Cannabinoids JWH-081 and JWH-210
por: Cha, Hye Jin, et al.
Publicado: (2015)

Dependence Potential of the Synthetic Cannabinoids JWH-073, JWH-081, and JWH-210: In Vivo and In Vitro Approaches
por: Cha, Hye Jin, et al.
Publicado: (2014)

Phytoestrogens Enhance the Vascular Actions of the Endocannabinoid Anandamide in Mesenteric Beds of Female Rats
por: Peroni, Roxana N., et al.
Publicado: (2012)

Enhancement of Anandamide-Mediated Endocannabinoid Signaling Corrects Autism-Related Social Impairment
por: Wei, Don, et al.
Publicado: (2016)

The Role of the Endocannabinoids 2-AG and Anandamide in Clinical Symptoms and Treatment Outcome in Veterans with PTSD
por: Leen, N.A., et al.
Publicado: (2022)

Activation of cannabinoid receptor type 2 by JWH133 alleviates bleomycin-induced pulmonary fibrosis in mice
por: Fu, Qiang, et al.
Publicado: (2017)

Modified Alginate-Based Hydrogel as a Carrier of the CB2 Agonist JWH133 for Bone Engineering
por: Zhou, Wei, et al.
Publicado: (2021)

Positive association between plasmatic levels of orexin A and the endocannabinoid-derived 2-arachidonoyl lysophosphatidic acid in Alzheimer’s disease
por: Forte, Nicola, et al.
Publicado: (2022)

In Vivo Bio-Activation of JWH-175 to JWH-018: Pharmacodynamic and Pharmacokinetic Studies in Mice
por: Tirri, Micaela, et al.
Publicado: (2022)

Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation
por: Bluett, R J, et al.
Publicado: (2014)

Membrane-mediated action of the endocannabinoid anandamide on membrane proteins: implications for understanding the receptor-independent mechanism
por: Medeiros, Djalma, et al.
Publicado: (2017)

Effects of tumour necrosis factor α upon the metabolism of the endocannabinoid anandamide in prostate cancer cells
por: Karlsson, Jessica, et al.
Publicado: (2017)

Treatment with CB(2) Agonist JWH-133 Reduces Histological Features Associated with Erectile Dysfunction in Hypercholesterolemic Mice
por: Fraga-Silva, Rodrigo Araujo, et al.
Publicado: (2013)

Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist
por: Hashiesh, Hebaallah Mamdouh, et al.
Publicado: (2021)

CB2 Receptor Agonist JWH133 Activates AMPK to Inhibit Growth of C6 Glioma Cells
por: Wang, Feng, et al.
Publicado: (2019)

Acetylation of conserved DVL-1 lysines regulates its nuclear translocation and binding to gene promoters in triple-negative breast cancer
por: Sharma, Monica, et al.
Publicado: (2019)

Hippocampal 2-Arachidonoyl Glycerol Signaling Regulates Time-of-Day- and Stress-Dependent Effects on Rat Short-Term Memory
por: Santori, Alessia, et al.
Publicado: (2020)

Blood Level of 2-arachidonoyl glycerol (2-AG), Neuropeptide Y and Omentin and Their Correlation with Food Habits in Obese Women
por: Rahmanian, Mozhdeh, et al.
Publicado: (2020)

Excess of the endocannabinoid anandamide during lactation induces overweight, fat accumulation and insulin resistance in adult mice
por: Aguirre, Carolina A, et al.
Publicado: (2012)

The endocannabinoid anandamide has an anti-inflammatory effect on CCL2 expression in vascular smooth muscle cells
por: Pflüger-Müller, Beatrice, et al.
Publicado: (2020)

Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome through Modulation of Microbiome in the Gut-Lung Axis
por: Sultan, Muthanna, et al.
Publicado: (2021)

The Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome by Downregulating miRNA that Target Inflammatory Pathways
por: Sultan, Muthanna, et al.
Publicado: (2021)

Anti-Tumorigenic Effect of a Novel Derivative of 2-Hydroxyoleic Acid and the Endocannabinoid Anandamide on Neuroblastoma Cells
por: Golan, Hana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oql67uciqgmrpdd5n3u534bm21